STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

IBEX Reports Record Start to Fiscal 2026, Raises Full Year Guidance

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

IBEX (Nasdaq: IBEX) reported a record start to fiscal 2026 for the quarter ended September 30, 2025 with Revenue $151.2M (+16.5% YoY), Net income $12.0M, and Adjusted EBITDA $19.5M (+24.9% YoY). Diluted EPS was $0.82 (+91% YoY) and adjusted EPS was $0.90 (+74% YoY). Free cash flow rose to $8.0M from $4.1M, and net cash improved to $21.1M. Management raised fiscal 2026 guidance to Revenue $605–$620M (from $590–$610M) and Adjusted EBITDA $78–$81M (from $75–$79M). Capital expenditures were $7.6M for the quarter with FY26 capex guidance of $20–$25M. The company cited strength in Retail & E-commerce, HealthTech, and Travel verticals as growth drivers.

IBEX (Nasdaq: IBEX) ha registrato un inizio record del 2026 fiscale per il trimestre terminato il 30 settembre 2025 con Ricavi 151,2 milioni di dollari (+16,5% YoY), utile netto 12,0 milioni di dollari e EBITDA rettificato 19,5 milioni di dollari (+24,9% YoY). L'EPS diluito è stato 0,82 dollari (+91% YoY) e l' è stato 0,90 dollari (+74% YoY). Il free cash flow è aumentato a 8,0 milioni di dollari da 4,1 milioni, e il net cash è migliorato a 21,1 milioni di dollari. La direzione ha alzato le previsioni per il 2026 fiscale a Ricavi 605–620 milioni di dollari (da 590–610 milioni) e EBITDA rettificato 78–81 milioni di dollari (da 75–79). Le spese in conto capitale sono state di 7,6 milioni di dollari per il trimestre con linee guida capex per FY26 di 20–25 milioni di dollari. L’azienda ha citato la forza nei verticali Retail & E-commerce, HealthTech e Travel come motori di crescita.

IBEX (Nasdaq: IBEX) informó un inicio récord para el año fiscal 2026 para el trimestre que terminó el 30 de septiembre de 2025 con ingresos de 151,2 millones de dólares (+16,5% interanual), ganancias netas de 12,0 millones de dólares y EBITDA ajustado de 19,5 millones de dólares (+24,9% interanual). Las ganancias por acción diluidas fueron de 0,82 dólares (+91% interanual) y las EPS ajustadas fueron de 0,90 dólares (+74% interanual). El flujo de caja libre aumentó a 8,0 millones de dólares desde 4,1 millones, y el efectivo neto mejoró a 21,1 millones de dólares. La dirección elevó las previsiones para el año fiscal 2026 a Ingresos 605–620 millones de dólares (desde 590–610) y EBITDA ajustado 78–81 millones de dólares (desde 75–79). Las inversiones de capital (capex) fueron de 7,6 millones de dólares para el trimestre con la guía de capex para FY26 de 20–25 millones de dólares. La empresa citó fortaleza en los sectores Retail & E-commerce, HealthTech y Travel como motores de crecimiento.

IBEX (Nasdaq: IBEX)는 2025년 9월 30일 종료된 분기의 2026 회계연도 시작이 기록적으로 좋았다고 보고했습니다. 매출은 1억5120만 달러(+16.5% YoY), 순이익 1,200만 달러, 조정 EBITDA 1,950만 달러(+24.9% YoY)를 기록했습니다. 희석된 주당순이익은 0.82달러(+91% YoY), 조정 EPS는 0.90달러(+74% YoY)였습니다. 자유현금흐름은 800만 달러로 증가했고 순현금은 2110만 달러로 개선되었습니다. 경영진은 FY2026 가이던스를 매출 605–620백만 달러로 상향했고 (기존 590–610) 조정 EBITDA를 78–81백만 달러로 제시했습니다 (기존 75–79). 분기 CAPEX는 760만 달러였고 FY26 CAPEX 가이던스는 2000만–2500만 달러였습니다. 회사는 소매 및 전자상거래(Retail & E-commerce), HealthTech, Travel 부문에서의 강세를 성장 동인으로 꼽았습니다.

IBEX (Nasdaq: IBEX) a enregistré un départ record pour l’exercice 2026 pour le trimestre clos le 30 septembre 2025 avec des revenus de 151,2 millions de dollars (+16,5 % YoY), un bénéfice net de 12,0 millions de dollars et un EBITDA ajusté de 19,5 millions de dollars (+24,9 % YoY). L’EPS dilué était de 0,82 dollar (+91 % YoY) et l’EPS ajusté était de 0,90 dollar (+74 % YoY). Le flux de trésorerie disponible a augmenté à 8,0 millions de dollars et la trésorerie nette s’est améliorée à 21,1 millions de dollars. La direction a relevé les prévisions pour l’exercice 2026 à Revenus 605–620 millions de dollars (contre 590–610) et EBITDA ajusté 78–81 millions de dollars (contre 75–79). Les dépenses d’investissement (CAPEX) du trimestre étaient de 7,6 millions de dollars avec une prévision CAPEX FY26 de 20–25 millions de dollars. L’entreprise a cité la force dans les verticales Retail & E-commerce, HealthTech et Travel comme moteurs de croissance.

IBEX (Nasdaq: IBEX) meldete einen rekordmäßigen Start ins Geschäftsjahr 2026 für das Quartal zum 30. September 2025 mit Umsatz von 151,2 Mio. USD (+16,5 % YoY), Nettoeinkommen von 12,0 Mio. USD und angepasstes EBITDA von 19,5 Mio. USD (+24,9 % YoY). Diluted EPS betrug 0,82 USD (+91 % YoY) und angepasstes EPS 0,90 USD (+74 % YoY). Free Cash Flow stieg auf 8,0 Mio. USD von 4,1 Mio., und Nettoliquidität verbesserte sich auf 21,1 Mio. USD. Das Management hob die Guidance für das Geschäftsjahr 2026 auf Umsatz 605–620 Mio. USD (von 590–610) und angepasstes EBITDA 78–81 Mio. USD (von 75–79) an. Capital Expenditures betrugen 7,6 Mio. USD für das Quartal mit FY26 Capex Guidance von 20–25 Mio. USD. Das Unternehmen verwies auf Stärke in den Bereichen Retail & E-commerce, HealthTech und Travel als Wachstumstreiber.

IBEX (Nasdaq: IBEX) أبلغت عن بداية قياسية للسنة المالية 2026 للشهر المالي المـُنتهي في 30 سبتمبر 2025، بمبيعات قدرها 151.2 مليون دولار (+16.5% سنويًا)، وصافي دخل قدره 12.0 مليون دولار و EBITDA المعدل قدره 19.5 مليون دولار (+24.9% سنويًا). كان الهامش المخفّض للسهم 0.82 دولار (+91% سنويًا) وEPS المعدل كان 0.90 دولار (+74% سنويًا). ارتفع التدفق النقدي الحر إلى 8.0 ملايين دولار من 4.1 ملايين، وتحسن النقد الصافي إلى 21.1 مليون دولار. رفعت الإدارة التوجيه للسنة المالية 2026 إلى إيرادات 605–620 مليون دولار (من 590–610) و EBITDA المعدل 78–81 مليون دولار (من 75–79). كانت النفقات الرأسمالية 7.6 مليون دولار للربع مع توجيه CAPEX للسنة المالية 2026 إلى 20–25 مليون دولار. أشارت الشركة إلى القوة في قطاعات Retail & E-commerce، HealthTech، وTravel كمحركات للنمو.

Positive
  • Revenue +16.5% YoY to $151.2M
  • Adjusted EBITDA +24.9% YoY to $19.5M
  • Adjusted EPS +74% YoY to $0.90
  • EPS +91% YoY to $0.82
  • Fiscal 2026 revenue guidance increased to $605–$620M
  • Free cash flow increased to $8.0M from $4.1M
Negative
  • Quarterly capital expenditures rose to $7.6M from $3.6M
  • Share repurchases of $2.7M used cash during the quarter

Insights

Strong quarter: double‑digit revenue growth, large adjusted EPS gain, and raised fiscal 2026 revenue and adjusted EBITDA guidance.

Revenue rose to $151.2 million, up 16.5% year‑over‑year, adjusted EPS reached $0.90 (up 74%), and adjusted EBITDA increased to $19.5 million with margin expansion to 12.9%. Growth concentrated in Retail & E‑commerce, HealthTech, and Travel, Transportation and Logistics. Operating cash flow and free cash flow improved, and the company repurchased shares for $2.7 million, boosting diluted EPS.

Drivers and caution: higher revenue from offshore, lower SG&A as a percent of revenue, favorable FX, and share repurchases supported profitability. Capital expenditures rose to $7.6 million to add capacity. The company raised fiscal 2026 revenue guidance to $605–620 million and adjusted EBITDA to $78–81 million. The company did not provide a quantitative reconciliation of forward‑looking non‑GAAP adjusted EBITDA, which limits comparability. Key risks include execution of capacity expansion, sustainability of top‑vertical growth, and FX or tax effects that influenced this quarter.

Items to watch over the next 12 months include quarterly revenue and margin trends versus the new guidance, progress on AI Automate Agent deployments, changes in days sales outstanding affecting cash flow, and any updated reconciliation of forward‑looking non‑GAAP metrics during fiscal reporting. Monitor results at the next quarterly report and commentary on the raised guidance on or around fiscal 2026 milestones.

  • Record first quarter Revenue, Adjusted EBITDA, EPS, Adjusted EPS, and Free Cash Flow
  • Revenue grew 16.5% versus prior year quarter
  • EPS grew 91% year-over-year to $0.82 and adjusted EPS grew 74% to $0.90
  • Raises Fiscal Year Guidance

WASHINGTON, Nov. 06, 2025 (GLOBE NEWSWIRE) -- IBEX Limited (“ibex”) (Nasdaq: IBEX), a leading provider in global business process outsourcing and end-to-end customer engagement technology solutions, today announced financial results for its first fiscal quarter ended September 30, 2025.

 Three months ended September 30,
($ millions, except per share amounts) 2025   2024  Change
Revenue$151.2  $129.7  16.5%
Net income$12.0  $7.5  59.9%
Net income margin 8.0%  5.8% 220 bps 
Adjusted net income (1)$13.1  $9.0  45.4%
Adjusted net income margin (1) 8.7%  7.0% 170 bps 
Adjusted EBITDA (1)$19.5  $15.6  24.9%
Adjusted EBITDA margin (1) 12.9%  12.0% 90 bps 
Earnings per share - diluted (2)$0.82  $0.43  91.4%
Adjusted earnings per share - diluted (1,2)$0.90  $0.52  74.1%
      
(1)See accompanying Exhibits for the reconciliation of each non-GAAP measure to its most directly comparable GAAP measure.
(2)The current period percentages are calculated based on exact amounts, and therefore may not recalculate exactly using rounded numbers as presented.
 

“I am pleased to report that ibex carried the momentum we built through fiscal 2025 into 2026, delivering an outstanding first quarter with revenue growth of 16.5% and adjusted EPS growth of 74%, as we continue to separate ourselves from the pack in the BPO market,” said Bob Dechant, ibex CEO. “Our sustained double digit revenue growth highlights our competitive differentiation in the CX space. We continue to drive exceptional operational delivery for our existing clients enabling us to win significant market share from our competition.”

“I am proud of our new logo engine that continues to win trophy clients, positioning us well for continued growth and margin expansion, as well as the progress we have made in our AI Automate Agent deployments for our clients. Collectively, this continues to validate our position as a leader among our competition in the CX space.”

First Quarter Financial Performance
Revenue

  • Revenue of $151.2 million, an increase of 16.5% from $129.7 million in the prior year quarter. Growth was driven in our top three verticals; Retail & E-commerce (+25.0%), HealthTech (+19.5%), and Travel, Transportation and Logistics (+15.4%), along with continued growth in the digital acquisition business and a return to growth in FinTech.

Net Income and Earnings Per Share

  • Net income increased to $12.0 million compared to $7.5 million in the prior year quarter. Net income was favorably impacted by revenue growth in our higher margin offshore regions, lower selling, general, and administrative expenses as a percentage of revenue, lower income tax expenses, and favorable foreign currency impacts compared to the prior year quarter.
  • Net income margin increased to 8.0% compared to 5.8% in the prior year quarter.
  • Diluted earnings per share increased to $0.82 compared to $0.43 in the prior year quarter, primarily due to higher net income and lower diluted shares outstanding as a result of our share repurchase activities during fiscal 2025.
  • Non-GAAP adjusted net income increased to $13.1 million compared to $9.0 million in the prior year quarter (see Exhibit 1 for reconciliation).
  • Non-GAAP adjusted diluted earnings per share increased to $0.90 compared to $0.52 in the prior year quarter (see Exhibit 1 for reconciliation).

Adjusted EBITDA

  • Adjusted EBITDA increased to $19.5 million compared to $15.6 million in the prior year quarter (see Exhibit 2 for reconciliation).
  • Adjusted EBITDA margin increased to 12.9% compared to 12.0% in the prior year quarter (see Exhibit 2 for reconciliation).

Cash Flow and Balance Sheet

  • Capital expenditures were $7.6 million compared to $3.6 million in the prior year quarter. The planned increase in capital expenditures during this quarter was driven by capacity expansion to meet strong demand in our highest margin regions.
  • Cash flow from operating activities was $15.7 million compared to $7.8 million in the prior year quarter, which was primarily driven by an increase in our revenues resulting in increased profitability, as well as a lower use of working capital driven by an improvement in days sales outstanding.
  • Free cash flow was $8.0 million compared to $4.1 million in the prior year quarter (see Exhibit 3 for reconciliation).
  • During the quarter, we repurchased 91,658 shares for $2.7 million.
  • Net cash was $21.1 million, an improvement of $7.4 million compared to net cash of $13.7 million as of June 30, 2025 (see Exhibit 4 for reconciliation).

First Quarter Review and Fiscal 2026 Business Outlook
“In the first quarter, we achieved outstanding revenue growth and profitability, once again, allowing us to build on our existing momentum entering fiscal 2026. Our revenue growth drove increased operating leverage, and positioned us to post record first quarter adjusted EBITDA margin of 12.9%, adjusted EPS of $0.90, and free cash flow of $8 million,” said Taylor Greenwald, CFO of ibex.

“Our continued strong financial results and healthy balance sheet are enabling strategic investments in our growing AI capabilities and sales resources, as well as further expansion into strategic markets and in our top performing geographies. Importantly, with our outstanding start to the fiscal year, we have the confidence in our business to raise our revenue and adjusted EBITDA guidance for fiscal year 2026.”

Fiscal Year 2026 Guidance

  • Revenue is expected to be in the range of $605 to $620 million, up from $590 to $610 million.
  • Adjusted EBITDA is expected to be in the range of $78 to $81 million, up from $75 to $79 million.
  • Capital expenditures are expected to remain in the range of $20 to $25 million.

Conference Call and Webcast Information
IBEX Limited will host a conference call and live webcast to discuss its first quarter of fiscal year 2026 financial results at 4:30 p.m. Eastern Time today, November 6, 2025. We will also post to this section of our website the earning slides, which will accompany our conference call and live webcast, and encourage you to review the information that we make available on our website.

Live and archived webcasts can be accessed at: https://investors.ibex.co/.

Financial Information
This announcement does not contain sufficient information to constitute an interim financial report as defined in Financial Accounting Standards ASC 270, “Interim Reporting.” The financial information in this press release has not been audited.

Non-GAAP Financial Measures
We present non-GAAP financial measures because we believe that they and other similar measures are widely used by certain investors, securities analysts and other interested parties as supplemental measures of performance and liquidity. We also use these measures internally to establish forecasts, budgets and operational goals to manage and monitor our business, as well as evaluate our underlying historical performance, as we believe that these non-GAAP financial measures provide a more helpful depiction of our performance of the business by encompassing only relevant and manageable events, enabling us to evaluate and plan more effectively for the future. The non-GAAP financial measures may not be comparable to other similarly titled measures of other companies, have limitations as analytical tools, and should not be considered in isolation or as a substitute for analysis of our operating results as reported in accordance with accounting principles generally accepted in the United States (“GAAP”). Non-GAAP financial measures and ratios are not measurements of our performance, financial condition or liquidity under GAAP and should not be considered as alternatives to operating profit or net income / (loss) or as alternatives to cash flow from operating, investing or financing activities for the period, or any other performance measures, derived in accordance with GAAP.

ibex is not providing a quantitative reconciliation of forward-looking non-GAAP adjusted EBITDA to the most directly comparable GAAP measure because it is unable to predict with reasonable certainty the ultimate outcome of certain significant items without unreasonable effort. These items include, but are not limited to, non-recurring expenses, foreign currency gains and losses, and stock-based compensation expense. These items are uncertain, depend on various factors, and could have a material impact on GAAP reported results for the guidance period.

About ibex
ibex helps the world’s preeminent brands more effectively engage their customers with services ranging from customer support, technical support, inbound/outbound sales, business intelligence and analytics, digital demand generation, and CX surveys and feedback analytics.

Forward Looking Statements
In addition to historical information, this press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by terminology such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “expect,” “predict,” “potential,” “forecast,” or the negative of these terms or other similar expressions. These statements include, but are not limited to, statements regarding our future financial and operating performance, including our outlook and guidance, and our strategies, priorities and business plans. Our expectations and beliefs regarding these matters may not materialize, and actual results in future periods are subject to risks and uncertainties that could cause actual results to differ materially from those projected. Factors that could impact our actual results include: our ability to attract new business and retain key clients; our profitability based on our utilization, pricing and managing costs; the potential for our clients or potential clients to consolidate; our clients deciding to enter into or further expand their insourcing activities and current trends toward outsourcing services may reverse; general economic uncertainty in global markets and unfavorable economic conditions, including inflation, rising interest rates, recession, foreign exchange fluctuations and supply-chain issues; our ability to manage our international operations, particularly in the Philippines, Jamaica, Pakistan and Nicaragua; natural events, health epidemics, global geopolitical conditions, including developing or ongoing conflicts, widespread civil unrest, terrorist attacks and other attacks of violence involving any of the countries in which we or our clients operate; our ability to anticipate, develop and implement information technology solutions that keep pace with evolving industry standards and changing client demands, including the effective adoption of Artificial Intelligence into our offerings; our ability to recruit, engage, motivate, manage and retain our global workforce; our ability to comply with applicable laws and regulations, including those regarding privacy, data protection and information security, employment and anti-corruption; the effect of cyberattacks or cybersecurity vulnerabilities on our information technology systems; the impact of tax matters, including new legislation and actions by taxing authorities; and other factors discussed in the “Risk Factors” described in our periodic reports filed with the U.S. Securities and Exchange Commission (“SEC”), including our annual reports on Form 10-K, quarterly reports on Form 10-Q, and past filings on Form 20-F, and any other risk factors we include in subsequent filings with the SEC. Because of these uncertainties, you should not make any investment decisions based on our estimates and forward-looking statements. Except as required by law, we undertake no obligation to publicly update any forward-looking statements for any reason after the date of this press release whether as a result of new information, future events or otherwise.

IR Contact:  Michael Darwal, Deputy CFO, President ibex Digital, ibex, michael.darwal@ibex.co
Media Contact:  Daniel Burris, VP, Marketing and Communication, ibex, daniel.burris@ibex.co

 
IBEX LIMITED AND SUBSIDIARIES
Consolidated Balance Sheets
(Unaudited)
(in thousands)
 
 September 30,
2025
 June 30,
2025
Assets   
Current assets   
Cash and cash equivalents$22,694  $15,350 
Accounts receivable, net 116,032   117,136 
Prepaid expenses 10,492   9,443 
Due from related parties    40 
Tax advances and receivables 1,505   1,522 
Other current assets 2,029   2,128 
Total current assets 152,752   145,619 
    
Non-current assets   
Property and equipment, net 36,541   32,563 
Operating lease assets 59,166   62,276 
Goodwill 11,832   11,832 
Deferred tax asset, net 8,225   7,163 
Other non-current assets 15,341   13,762 
Total non-current assets 131,105   127,596 
Total assets$283,857  $273,215 
    
Liabilities and stockholders' equity   
Current liabilities   
Accounts payable and accrued liabilities$25,391  $18,692 
Accrued payroll and employee-related liabilities 36,101   38,588 
Current deferred revenue 6,162   5,498 
Current operating lease liabilities 14,273   14,332 
Current debt 847   823 
Due to related parties    22 
Income taxes payable 1,236   1,986 
Total current liabilities 84,010   79,941 
    
Non-current liabilities   
Non-current deferred revenue 1,080   1,130 
Non-current operating lease liabilities 50,695   53,804 
Long-term debt 726   796 
Other non-current liabilities 3,721   3,235 
Total non-current liabilities 56,222   58,965 
Total liabilities 140,232   138,906 
    
Stockholders' equity   
Common Stock 2   1 
Additional paid-in capital 221,594   218,241 
Treasury stock (106,018)  (103,338)
Accumulated other comprehensive loss (9,736)  (6,336)
Retained earnings 37,783   25,741 
Total stockholders' equity 143,625   134,309 
Total liabilities and stockholders' equity$283,857  $273,215 
        


IBEX LIMITED AND SUBSIDIARIES
Consolidated Statements of Comprehensive Income
(Unaudited)
(in thousands, except per share data)
 
 Three Months Ended September 30,
  2025   2024 
Revenue$151,179  $129,717 
    
Cost of services (exclusive of depreciation and amortization presented separately below) 106,577   90,041 
Selling, general and administrative 26,525   26,215 
Depreciation and amortization 4,378   4,369 
Total operating expenses 137,480   120,625 
Income from operations 13,699   9,092 
    
Interest income 30   583 
Interest expense (217)  (162)
Income before income taxes 13,512   9,513 
    
Provision for income tax expense (1,470)  (1,982)
Net income$12,042  $7,531 
    
Other comprehensive income   
Foreign currency translation adjustments$(1,212) $1,388 
Unrealized (loss) / gain on cash flow hedging instruments, net of tax (2,188)  379 
Total other comprehensive (loss) / income (3,400)  1,767 
Total comprehensive income$8,642  $9,298 
    
Net income per share   
Basic$0.90  $0.45 
Diluted$0.82  $0.43 
    
Weighted average common shares outstanding   
Basic 13,360   16,880 
Diluted 14,609   17,490 
        


IBEX LIMITED AND SUBSIDIARIES
Consolidated Statements of Cash Flows
(Unaudited)
(in thousands)
 
 Three Months Ended September 30,
  2025   2024 
CASH FLOWS FROM OPERATING ACTIVITIES   
Net income$12,042  $7,531 
Adjustments to reconcile net income to net cash provided by operating activities:   
Depreciation and amortization 4,378   4,369 
Noncash lease expense 3,437   3,326 
Deferred income tax (1,062)  (130)
Stock-based compensation expense 2,550   670 
Allowance for expected credit losses 52   83 
Change in assets and liabilities:   
Decrease / (increase) in accounts receivable 1,015   (7,649)
Increase in prepaid expenses and other current assets (3,472)  (1,735)
(Decrease) / increase in accounts payable and accrued liabilities (311)  4,574 
Increase in deferred revenue 614   79 
Decrease in operating lease liabilities (3,573)  (3,356)
Net cash inflow from operating activities 15,670   7,762 
    
CASH FLOWS FROM INVESTING ACTIVITIES   
Purchase of property and equipment (7,639)  (3,630)
Net cash outflow from investing activities (7,639)  (3,630)
    
CASH FLOWS FROM FINANCING ACTIVITIES   
Proceeds from line of credit    60 
Repayments of line of credit    (60)
Proceeds from the exercise of options 2,412   382 
Principal payments on finance leases (292)  (171)
Purchase of treasury shares (2,767)  (4,807)
Net cash outflow from financing activities (647)  (4,596)
Effects of exchange rate difference on cash and cash equivalents (40)  49 
Net increase / (decrease) in cash and cash equivalents 7,344   (415)
Cash and cash equivalents, beginning 15,350   62,720 
Cash and cash equivalents, ending$22,694  $62,305 
        
IBEX LIMITED AND SUBSIDIARIES
Reconciliation of GAAP Financial Measures to Non-GAAP Financial Measures
        

EXHIBIT 1: Adjusted net income, adjusted net income margin, and adjusted earnings per share

We define adjusted net income as net income before the effect of the following items: severance costs, foreign currency gains and losses, and stock-based compensation expense, net of the tax impact of such adjustments. We define adjusted net income margin as adjusted net income divided by revenue. We define adjusted earnings per share as adjusted net income divided by weighted average diluted shares outstanding.

The following table provides a reconciliation of net income to adjusted net income, net income margin to adjusted net income margin, and diluted earnings per share to adjusted earnings per share for the periods presented:

 Three months ended September 30,
($000s, except per share amounts) 2025   2024 
Net income$12,042  $7,531 
Net income margin 8.0%  5.8%
    
Severance costs 159    
Foreign currency (gain) / loss (1,320)  1,457 
Stock-based compensation expense 2,550   670 
Total adjustments$1,389  $2,127 
Tax impact of adjustments1 (297)  (626)
Adjusted net income$13,134  $9,032 
Adjusted net income margin 8.7%  7.0%
    
Diluted earnings per share$0.82  $0.43 
Per share impact of adjustments to net income 0.08   0.09 
Adjusted earnings per share$0.90  $0.52 
    
Weighted average diluted shares outstanding 14,609   17,490 

_______________
1The tax impact of each adjustment is calculated using the effective tax rate in the relevant jurisdictions.

EXHIBIT 2:  EBITDA, adjusted EBITDA, and adjusted EBITDA margin

EBITDA is a non-GAAP profitability measure that represents net income before the effect of the following items: interest expense, income tax expense, and depreciation and amortization. Adjusted EBITDA is a non-GAAP profitability measure that represents EBITDA before the effect of the following items: severance costs, interest income, foreign currency gains and losses, and stock-based compensation expense. Adjusted EBITDA margin is a non-GAAP profitability measure that represents adjusted EBITDA divided by revenue.

The following table provides a reconciliation of net income to EBITDA and adjusted EBITDA and net income margin to adjusted EBITDA margin for the periods presented:

 Three months ended September 30,
($000s) 2025   2024 
Net income$12,042  $7,531 
Net income margin 8.0%  5.8%
    
Interest expense 217   162 
Income tax expense 1,470   1,982 
Depreciation and amortization 4,378   4,369 
EBITDA$18,107  $14,044 
Severance costs 159    
Interest income (30)  (583)
Foreign currency (gain) / loss (1,320)  1,457 
Stock-based compensation expense 2,550   670 
Adjusted EBITDA$19,466  $15,588 
    
Adjusted EBITDA margin 12.9%  12.0%
        

EXHIBIT 3: Free cash flow

We define free cash flow as net cash provided by operating activities less capital expenditures.

 Three months ended September 30,
($000s) 2025
  2024
Net cash provided by operating activities$15,670  $7,762 
Less: capital expenditures 7,639   3,630 
Free cash flow$8,031  $4,132 
        

EXHIBIT 4: Net cash

We define net cash as total cash and cash equivalents less debt.

 September 30,
 June 30,
($000s) 2025   2025 
Cash and cash equivalents$22,694  $15,350 
      
Debt     
Current$847  $823 
Non-current 726   796 
Total debt$1,573  $1,619 
Net cash$21,121  $13,731 
        



FAQ

What were IBEX's revenue and revenue growth for Q1 FY2026 (ended Sept 30, 2025)?

IBEX reported $151.2M in revenue for Q1 FY2026, up 16.5% year‑over‑year.

How much did IBEX raise its fiscal 2026 revenue and adjusted EBITDA guidance on Nov 6, 2025?

Revenue guidance was raised to $605–$620M (from $590–$610M) and adjusted EBITDA to $78–$81M (from $75–$79M).

What were IBEX's EPS and adjusted EPS for Q1 FY2026 and how did they change year‑over‑year?

Diluted EPS was $0.82 (+91% YoY) and adjusted diluted EPS was $0.90 (+74% YoY).

How did IBEX's free cash flow and net cash position change in Q1 FY2026?

Free cash flow was $8.0M (vs $4.1M prior year) and net cash improved to $21.1M as of Sept 30, 2025.

Which verticals drove IBEX's Q1 FY2026 growth?

Top growth drivers were Retail & E‑commerce (+25.0%), HealthTech (+19.5%), and Travel, Transportation & Logistics (+15.4%).

What capital expenditure guidance did IBEX provide for fiscal 2026?

IBEX expects fiscal 2026 capital expenditures in the range of $20–$25M.
Ibex Ltd

NASDAQ:IBEX

IBEX Rankings

IBEX Latest News

IBEX Latest SEC Filings

IBEX Stock Data

491.42M
12.65M
13.05%
94.32%
0.95%
Information Technology Services
Services-computer Processing & Data Preparation
Link
United States
WASHINGTON